KCNJ18 Gene Thyrotoxic periodic paralysis type 2 Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Neurological Disorders
Doctor
Neurologist
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for KCNJ18 Gene Thyrotoxic periodic paralysis type 2 NGS Genetic DNA Test
A Genetic Counselling session to draw a pedigree chart of family members affected with KCNJ18 Gene Thyrotoxic periodic paralysis type 2
Test Details
The KCNJ18 gene is associated with a condition called thyrotoxic periodic paralysis type 2 (TPP2). TPP2 is a rare genetic disorder characterized by episodes of muscle weakness and paralysis, typically triggered by high levels of thyroid hormone in the blood (thyrotoxicosis). This condition is most commonly found in individuals of Asian descent.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variations or mutations that may be responsible for a particular condition. In the case of TPP2, NGS genetic testing can be used to identify mutations or variations in the KCNJ18 gene that may be causing the disorder.
By identifying the specific genetic mutation associated with TPP2, NGS testing can help with accurate diagnosis, genetic counseling, and potentially guide treatment decisions. It can also be used for carrier testing in family members of affected individuals.
It is important to note that NGS testing is typically performed by specialized laboratories and requires a healthcare provider’s order. The results of the genetic test should be interpreted by a qualified healthcare professional who can provide appropriate guidance and counseling based on the individual’s specific situation.
| Test Name | KCNJ18 Gene Thyrotoxic periodic paralysis type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for KCNJ18 Gene Thyrotoxic periodic paralysis type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KCNJ18 Gene Thyrotoxic periodic paralysis type 2 |
| Test Details |
The KCNJ18 gene is associated with a condition called thyrotoxic periodic paralysis type 2 (TPP2). TPP2 is a rare genetic disorder characterized by episodes of muscle weakness and paralysis, typically triggered by high levels of thyroid hormone in the blood (thyrotoxicosis). This condition is most commonly found in individuals of Asian descent. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously, allowing for the identification of genetic variations or mutations that may be responsible for a particular condition. In the case of TPP2, NGS genetic testing can be used to identify mutations or variations in the KCNJ18 gene that may be causing the disorder. By identifying the specific genetic mutation associated with TPP2, NGS testing can help with accurate diagnosis, genetic counseling, and potentially guide treatment decisions. It can also be used for carrier testing in family members of affected individuals. It is important to note that NGS testing is typically performed by specialized laboratories and requires a healthcare provider’s order. The results of the genetic test should be interpreted by a qualified healthcare professional who can provide appropriate guidance and counseling based on the individual’s specific situation. |
